Drug provides another treatment option for an early form of breast cancer
The drug anastrozole is effective in treating an early form of breast cancer, according to a clinical trial. The results of the trial show that anastrozole is as effective as tamoxifen for this type of breast cancer and could offer a new treatment option for post-menopausal women. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 11, 2015 Category: Science Source Type: news
Two Drugs Equal in Preventing Early Breast Cancer’s Return: Study
Women with ductal carcinoma in situ had similar outcomes with tamoxifen, anastrozole (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 11, 2015 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Oncology, Pharmacy, News, Source Type: news
Two Drugs Equal in Preventing Early Breast Cancer's Return: Study
Women with ductal carcinoma in situ had similar outcomes with tamoxifen, anastrozole (Source: WebMD Health)
Source: WebMD Health - December 11, 2015 Category: Consumer Health News Source Type: news
Medical News Today: Why does tamoxifen not work in some women with hormone-sensitive breast cancer?
Researchers suggest the reason tamoxifen does not work in some women with hormone-sensitive breast cancer could be because there is more than one single genetic marker involved. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 11, 2015 Category: Consumer Health News Tags: Breast Cancer Source Type: news
Drug provides another treatment option for an early form of breast cancer
(Queen Mary, University of London) The drug anastrozole is effective in treating an early form of breast cancer, according to a clinical trial led by Queen Mary University of London. The results of the IBIS-II DCIS trial show that anastrozole is as effective as tamoxifen for this type of breast cancer and could offer a new treatment option for post-menopausal women. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 11, 2015 Category: Cancer & Oncology Source Type: news
DCIS patients receiving anastrozole reported symptoms different from those receiving tamoxifen
(American Association for Cancer Research) Analysis of patient-reported outcomes (PRO), a secondary endpoint of the phase III, NSABP B-35 clinical trial, in which anastrazole and tamoxifen were compared in postmenopausal women with ductal carcinoma in-situ (DCIS) who underwent lumpectomy plus radiotherapy, found that there were no differences in outcomes related to quality of life but some differences in outcomes related to symptoms in the two treatment groups, according to data presented at the 2015 San Antonio Breast Cancer Symposium, held Dec. 8-12. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 11, 2015 Category: Cancer & Oncology Source Type: news
No significant differences in recurrence rates among women with DCIS taking anastrozole or tamoxifen
(American Association for Cancer Research) Postmenopausal women with ductal carcinoma in situ (DCIS) had similar outcomes with disease recurrence whether they took tamoxifen or the aromatase inhibitor anastrozole for five years after surgery, but women in the two groups had different side effects, according to results from the phase III IBIS-II DCIS clinical trial presented at the 2015 San Antonio Breast Cancer Symposium, held Dec. 8-12. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 11, 2015 Category: Cancer & Oncology Source Type: news
Why does tamoxifen work better in some women?
The anti-hormone therapy tamoxifen can reduce breast cancer recurrence by about half in women with hormone-sensitive breast cancer. But it works better in some women than others. Researchers are not sure why. New studies add to questions about predicting whether tamoxifen will be effective in an individual breast cancer patient. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 10, 2015 Category: Science Source Type: news
Why does tamoxifen work better in some women?
(University of Michigan Health System) New studies add to questions about predicting whether tamoxifen will be effective in an individual breast cancer patient. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 10, 2015 Category: Cancer & Oncology Source Type: news
Resistance of ER-positive breast cancer to tamoxifen therapy may be driven by APOBEC3B
(American Association for Cancer Research) Responses to tamoxifen were significantly prolonged by reducing levels of the enzyme APOBEC3B in preclinical models of estrogen receptor-positive breast cancer and significantly shortened by increasing levels of APOBEC3B, suggesting that APOBEC3B drives resistance to tamoxifen, according to data presented at the 2015 San Antonio Breast Cancer Symposium, held Dec. 8-12. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 10, 2015 Category: Cancer & Oncology Source Type: news
ACS Releases Long-term Care Guideline for Breast Cancer Survivors
By Stacy Simon The American Cancer Society and the American Society of Clinical Oncology have released a new Breast Cancer Survivorship Care Guideline to help breast cancer survivors and their primary care providers better manage their long-term care. The guideline was published December 7, 2015 in CA: A Cancer Journal for Clinicians, a journal of the American Cancer Society. It provides detailed recommendations for how and when to test for new or returning cancers, managing side effects, making healthy lifestyle changes, and coordinating care among primary care providers and specialists. The guideline is the third in a se...
Source: American Cancer Society :: News and Features - December 7, 2015 Category: Cancer & Oncology Tags: Breast Cancer Coping with Cancer Source Type: news
Safe to Take Antidepressants With Tamoxifen: Study
Title: Safe to Take Antidepressants With Tamoxifen: StudyCategory: Health NewsCreated: 12/4/2015 12:00:00 AMLast Editorial Review: 12/7/2015 12:00:00 AM (Source: MedicineNet Depression General)
Source: MedicineNet Depression General - December 7, 2015 Category: Psychiatry Source Type: news
Antidepressants With Tamoxifen Safe: Study
No greater risk of breast cancer recurrence seen (Source: WebMD Health)
Source: WebMD Health - December 4, 2015 Category: Consumer Health News Source Type: news
Safe to Take Antidepressants With Tamoxifen: Study
No greater risk of breast cancer recurrence seen (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 4, 2015 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Gynecology, Oncology, Pharmacy, Psychiatry, News, Source Type: news
Safe to Take Antidepressants with Tamoxifen
No greater risk of breast cancer recurrence seenSource: HealthDay
Related MedlinePlus Pages: Breast Cancer, Depression (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - December 4, 2015 Category: Consumer Health News Source Type: news
